Margaret Kranyak, MD


Margaret Kranyak, MD

Appointed: 1994

Margaret Kranyak, MD
Department: Radiation Oncology
Location: Fairview Hospital
Mail Code Fairview
18101 Lorain Avenue
Cleveland, OH 44111
Adults Only

Biographical Sketch

Margaret Kranyak, MD, has been on Staff at Cleveland Clinic since 1994. She serves as Division Chief of Radiation Oncology at the Moll Pavilion, Fairview Hospital. She serves on various hospital committees, and chairs the Breast Cancer Tumor Conference and the Oncology Process Improvement Committee. Dr. Kranyak's primary interest are prostate and breast cancer, but she treats all types of cancer except for pediatric, and is considered a Generalist in Radiation Oncology.  Dr. Kranyak has recently initiated a new support program for men entitled "For Men Only" which will hopefully continue to grow.

The Moll Pavilion boasts the latest technology in external beam radiation therapy, and offers state-of-the-art treatment for the majority of patients. Special procedures such as Gamma Knife are referred to Cleveland Clinic's main campus.

Education & Fellowships

Residency - University of Virginia Health Sciences Center
Radiation Oncology
Medical School - University of Cincinnati College of Medicine
Cincinnati, OH USA
Undergraduate - University of Cincinnati
Cincinnati, OH USA


  • Radiation Oncology
  • Radiation Oncology- Hospice and Palliative Medicine

Specialty Interests

Radiation oncology for prostate cancer, brachytherapy for prostate cancer, breast cancer,pallative medicine, psychosocial aspects of cancer care


  • American Society of Radiation Oncology
  • Ohio Medical Association
  • Christian Medical and Dental Association

Treatment & Services

  • Brachytherapy
  • External Beam Radiotherapy
  • General Radiation Oncology
  • Radiation Therapy

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Kranyak's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

Languages Spoken

  • English
Cleveland Clinic Mobile Site